Illumina Inc (ILMN) ニュース

Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications

Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications PR Newswire AMSTERDAM, Dec...

Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

SALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic...

Illumina announces expansion of TruSight Oncology portfolio

Illumina announces expansion of TruSight Oncology portfolio PR Newswire SAN DIEGO, Nov. 19, 2024 The latest...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Illumina To Webcast Upcoming Investor Conferences

Illumina To Webcast Upcoming Investor Conferences PR Newswire SAN DIEGO, Nov. 6, 2024 SAN DIEGO, Nov. 6, 2024...

Form 8-K - Current report

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024 PR Newswire SAN DIEGO, Nov. 4, 2024 Core Illumina revenue of $1.1...

Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting

Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting PR Newswire SAN...

Form 3 - Initial statement of beneficial ownership of securities

Form 144 - Report of proposed sale of securities